← Human Trials & Peer-Reviewed Studies
Impact of preventive osteoporosis education on patient behavior: immediate and 3-month follow-up.
Plain-language guide to PMID 14716192 (2004): randomized controlled trial of Vitamin D and Calcium in 195 women.
Key Facts
- PMID
- 14716192
- Journal
- Menopause (New York, N.Y.)
- Year
- 2004
- Study type
- Randomized Controlled Trial
- Authors
- Kulp JL et al. (3 authors)
- DOI
- 10.1097/01.GME.0000079221.19081.11
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Vitamin D and Calcium, published as a randomized controlled trial.
Who Took Part
The study group was 195 women.
The age groups tagged for this paper are adults, middle-aged adults, older adults and people over 80, women only.
A total of 195 women between 35 and 80 years of age without documented osteopenia or osteoporosis, who presented for a gynecological examination in an outpatient setting, were enrolled.
Of this number, 98 women were randomly assigned to the intervention group that viewed the video before their office visit, and 97 women were assigned to a control group and saw their physician in a routine manner.
How the Study Was Run
The researchers set it up as a randomized study.
Because people in this Vitamin D study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
After their visit, all participants answered a questionnaire that assessed their knowledge of osteoporosis and baseline health-related behaviors.
Frequencies were compared using the Fisher exact test (2-tailed).
Continuous variables were analyzed using the Student's t test.
What Was Measured
The subject headings attached to it are Calcium, Dietary Supplements, Estrogen Replacement Therapy, Exercise, Health Behavior, Health Knowledge, Attitudes, Practice and New Jersey.
What This Means in Plain Language
The paper is a randomized study of Vitamin D and Calcium in 195 women.
Its findings take up roughly 4 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2004 (Menopause (New York, N.Y.)), a journal based in United States.
More context: the related Vitamin D, K2, Magnesium and Zinc library page, all human trials.
Related Library Page
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.